Funding awarded
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID) awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2023 - 2028
- Multiomic approaches to treatment-shortening compound development and target identification awarded by Bill & Melinda Gates Foundation Principal Investigator 2024 - 2027
- Open AI/ML-assisted bacterial permeability platform awarded by Bill & Melinda Gates Foundation Principal Investigator 2024 - 2026
- Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2022 - 2026
- Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2021 - 2026
- Weill Cornell Medicine Physician-Scientist Academy awarded by Burroughs Wellcome Fund Principal Investigator 2019 - 2025
- Tri-I Training Program in Metabolomics awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2019 - 2025
- UM1 Consortium for the Design of TB Drug Regimens awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2024 - 2029
- Tri-Institutional Tuberculosis Research Advancement Center awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2022 - 2027
- The Transmission Biology of Mycobacterium Tuberculosis awarded by National Institute of Allergy & Infectious Diseases Key Personnel 2021 - 2026
- Pathway Analysis in Tuberculosis awarded by National Institute of Allergy & Infectious Diseases Key Personnel 2020 - 2025
- Transporter function of the Mycobacterium tuberculosis PE/PPE proteins. awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2024 - 2028
- Defining the mechanism of coma in cerebral malaria awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2022 - 2027
- Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival awarded by National Institute on Aging Principal Investigator Subaward 2024 - 2026
- Bacterial and Host Heterogeneity in TB latency, persistence and progression awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2022 - 2026
- Metabolic determinants of Mtb virulence, vulnerability and variation - Core A awarded by National Cancer Institute Principal Investigator Subaward 2021 - 2026
- Metabolic determinants of Mtb virulence, vulnerability and variation - Core B awarded by National Cancer Institute Principal Investigator Subaward 2021 - 2026
- Metabolic determinants of Mtb virulence, vulnerability and variation - Project 2 awarded by National Cancer Institute Principal Investigator Subaward 2021 - 2026
- Metabolic determinants of Mtb virulence, vulnerability and variation - Project 3 awarded by National Cancer Institute Principal Investigator Subaward 2021 - 2026
- Mechanisms for potentiation with the BPaL regimen awarded by National Institute on Minority Health & Health Disparities Principal Investigator Subaward 2024 - 2025
- Bacteria and Host in TB Transmission awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2025